Natural killer (NK) cells, a subgroup of innate lymphoid cells, act as the first line of defense
against cancer. Although some evidence shows that NK cells can develop in secondary …

Macrophages phagocytize pathogens to initiate innate immunity and products from the
tumor microenvironment (TME) to mediate tumor immunity. The loss of tumor-associated …

Significant progress has been made in recent years toward realizing the potential of natural
killer (NK) cells for cancer immunotherapy. NK cells can respond rapidly to transformed and …

The ability of tumors to manage an immune‐mediated attack has been recently included in
the “next generation” of cancer hallmarks. In solid tumors, the microenvironment that is …

The highly restricted expression of B-cell maturation antigen (BCMA) on plasma cells makes
it an ideal target for chimeric antigen receptor (CAR) immune cell therapy against multiple …

Natural killer (NK) cells are the most responsive immune cells to exercise, displaying an
acute mobilization to the circulation during physical exertion. Recently, exercise-dependent …

Natural killer (NK) cells develop from common progenitors but diverge into distinct subsets,
which differ in cytokine production, cytotoxicity, homing, and memory traits. Given their …

Chemerin is an adipocyte‐secreted protein with autocrine/paracrine roles on adipose
development and function as well as endocrine roles in metabolism and immunity. Following …

Natural Killer (NK) cells are classically considered innate immune effector cells involved in
the first line of defense against infected and malignant cells. More recently, NK cells have …

Natural killer cells are powerful effectors of innate immunity that constitute a first line of
defense against cancer. NK cells express an array of germline-encoded receptors which …